José Manuel Caamaño – General Manager, Takeda Mexico
30.03.2015
Related Interviews
Mexico / María del Socorro Epata Lomelí - Executive Director, ANAFAM México
María del Socorro España Lomelí, the executive director of Mexico’s National Association of Manufacturers of Medicines (ANAFAM), speaks to PharmaBoardroom about ANAFAM’s evolving relationship with the Mexican government and the…
Mexico / Grupo Sanfer's Director on Expansion Across LatAm and Mexico's Segmented Public and Private Markets
Dagoberto Cortés Cervantes, president of Mexico’s National Association of Medicines Manufacturers (ANAFAM) and director of Grupo Sanfer/Hormona Mexico, outlines the expansion strategy that has led the manufacturing group to extend…
LatAm / Teva VP on Being a Global Player with a Local Approach
Back in Latin America after several years in the US and Europe, Teva LatAm Head and Mexico GM Rodrigo Fernandez explains how the affiliate has adapted its strategy across the…
MEA / The Dividends of Diversity in UAE Pharma Teams
Over the past few decades, the UAE has worked hard to attract top global talent to fill the gaps that its small local population was unable to. While the high…
Long Read / Belgium: One of a Kind
Encircled by heavyweight life sciences powerhouses of the likes of Germany, France and Switzerland, plucky Belgium nonetheless continues to astonish and project considerable influence when it comes to its abilities…
Leadership / Four Takeda Country Managers Discuss Top Priorities
Japanese-headquartered Takeda has been undergoing a transformation in recent years, becoming the global leader in rare diseases with the acquisition of Shire in 2018 and divesting ‘non-core’ assets in OTC…
